Drug intelligence / Profile preview

albumin + saline

Development stage
Unknown
Lead developer
Grifols
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intravenous
01

Overview

Albumin + saline refers to the combined use of human serum albumin (a plasma protein derived from human blood) and isotonic saline (sodium chloride solution) for intravenous administration. This combination is primarily used in clinical settings for fluid resuscitation, particularly in critically ill patients with hypovolemia, burns, or shock. Albumin acts as a colloid plasma expander by increasing oncotic pressure and drawing fluid into the intravascular space, while saline serves as a crystalloid volume expander that increases extracellular fluid volume. The combination may be chosen when both rapid plasma expansion and maintenance of oncotic pressure are desired. The SAFE trial demonstrated no significant difference in mortality between 4% albumin and normal saline for fluid resuscitation in ICU patients[5]. Albumin's mechanism includes maintaining colloidal osmotic pressure, stabilizing circulating blood volume, transporting various substances in the blood, providing antioxidant effects, and supporting capillary membrane integrity[1][4]. Saline provides isotonic volume expansion but does not contribute to oncotic pressure.

Brand names
AlburexAlbuminarAlbuminexAlbuteinAlbuked
Other names
human albumin + sodium chloridealbumin and saline combination

Beyond the preview

Go deeper on albumin + saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albumin + saline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call